- Home
- GANX vs AGAE Comparison
GANX vs AGAE Comparison
Compare GANX & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- AGAE
- Stock Information
- Founded
- GANX 2017
- AGAE 2017
- Country
- GANX United States
- AGAE United States
- Employees
- GANX N/A
- AGAE N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- AGAE Cable & Other Pay Television Services
- Sector
- GANX Health Care
- AGAE Telecommunications
- Exchange
- GANX Nasdaq
- AGAE Nasdaq
- Market Cap
- GANX 41.9M
- AGAE 48.5M
- IPO Year
- GANX 2021
- AGAE N/A
- Fundamental
- Price
- GANX $1.85
- AGAE $1.14
- Analyst Decision
- GANX Strong Buy
- AGAE
- Analyst Count
- GANX 4
- AGAE 0
- Target Price
- GANX $7.75
- AGAE N/A
- AVG Volume (30 Days)
- GANX 281.8K
- AGAE 39.0K
- Earning Date
- GANX 11-14-2024
- AGAE 11-14-2024
- Dividend Yield
- GANX N/A
- AGAE N/A
- EPS Growth
- GANX N/A
- AGAE N/A
- EPS
- GANX N/A
- AGAE N/A
- Revenue
- GANX N/A
- AGAE $9,256,023.00
- Revenue This Year
- GANX N/A
- AGAE N/A
- Revenue Next Year
- GANX $300.03
- AGAE N/A
- P/E Ratio
- GANX N/A
- AGAE N/A
- Revenue Growth
- GANX N/A
- AGAE 36.15
- 52 Week Low
- GANX $0.89
- AGAE $0.61
- 52 Week High
- GANX $5.33
- AGAE $1.57
- Technical
- Relative Strength Index (RSI)
- GANX 39.86
- AGAE 41.46
- Support Level
- GANX $1.64
- AGAE $1.13
- Resistance Level
- GANX $2.34
- AGAE $1.25
- Average True Range (ATR)
- GANX 0.27
- AGAE 0.07
- MACD
- GANX -0.09
- AGAE -0.00
- Stochastic Oscillator
- GANX 19.90
- AGAE 19.44
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.